
Stephen Sanders
Examiner (ID: 19298, Phone: (571)270-5308 , Office: P/2434 )
| Most Active Art Unit | 2434 |
| Art Unit(s) | 2434, 2439 |
| Total Applications | 325 |
| Issued Applications | 261 |
| Pending Applications | 0 |
| Abandoned Applications | 65 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10305478
[patent_doc_number] => 20150190478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-09
[patent_title] => 'NEW PROTECTING COMPOSITIONS FOR RECOMBINANTLY PRODUCED FACTOR VII'
[patent_app_type] => utility
[patent_app_number] => 14/567065
[patent_app_country] => US
[patent_app_date] => 2014-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6100
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14567065
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/567065 | NEW PROTECTING COMPOSITIONS FOR RECOMBINANTLY PRODUCED FACTOR VII | Dec 10, 2014 | Abandoned |
Array
(
[id] => 10263525
[patent_doc_number] => 20150148520
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-28
[patent_title] => 'SINGLE-CHAIN INSULIN AGONISTS EXHIBITING HIGH ACTIVITY AT THE INSULIN RECEPTOR'
[patent_app_type] => utility
[patent_app_number] => 14/563362
[patent_app_country] => US
[patent_app_date] => 2014-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 51
[patent_no_of_words] => 72952
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14563362
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/563362 | Single-chain insulin agonists exhibiting high activity at the insulin receptor | Dec 7, 2014 | Issued |
Array
(
[id] => 10254953
[patent_doc_number] => 20150139950
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-21
[patent_title] => 'ALISPORIVIR TO TREAT HEPATITIS C VIRUS INFECTION'
[patent_app_type] => utility
[patent_app_number] => 14/540469
[patent_app_country] => US
[patent_app_date] => 2014-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7629
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14540469
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/540469 | ALISPORIVIR TO TREAT HEPATITIS C VIRUS INFECTION | Nov 12, 2014 | Abandoned |
Array
(
[id] => 11046229
[patent_doc_number] => 20160243187
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-25
[patent_title] => 'METHODS OF TREATING ACUTE MYELOID LEUKEMIA WITH A FLT3 MUTATION'
[patent_app_type] => utility
[patent_app_number] => 15/027252
[patent_app_country] => US
[patent_app_date] => 2014-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 9951
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15027252
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/027252 | METHODS OF TREATING ACUTE MYELOID LEUKEMIA WITH A FLT3 MUTATION | Oct 29, 2014 | Abandoned |
Array
(
[id] => 10234346
[patent_doc_number] => 20150119340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-30
[patent_title] => 'FUSION PEPTIDE AND USE THEREOF FOR CELL MEMBRANE PENETRATING'
[patent_app_type] => utility
[patent_app_number] => 14/527427
[patent_app_country] => US
[patent_app_date] => 2014-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 8881
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14527427
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/527427 | FUSION PEPTIDE AND USE THEREOF FOR CELL MEMBRANE PENETRATING | Oct 28, 2014 | Abandoned |
Array
(
[id] => 11053321
[patent_doc_number] => 20160250283
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-01
[patent_title] => 'COMPOSITIONS AND METHODS FOR PROPHYLAXIS AND THERAPY OF CLOSTRIDIUM DIFFICILE INFECTION'
[patent_app_type] => utility
[patent_app_number] => 15/030898
[patent_app_country] => US
[patent_app_date] => 2014-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 7789
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15030898
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/030898 | COMPOSITIONS AND METHODS FOR PROPHYLAXIS AND THERAPY OF CLOSTRIDIUM DIFFICILE INFECTION | Oct 22, 2014 | Abandoned |
Array
(
[id] => 10824984
[patent_doc_number] => 20160171150
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-16
[patent_title] => 'Chemical Modulators of Pro-Apoptotic BAX and BCL-2 Polypeptides'
[patent_app_type] => utility
[patent_app_number] => 14/512131
[patent_app_country] => US
[patent_app_date] => 2014-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 32065
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14512131
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/512131 | Chemical Modulators of Pro-Apoptotic BAX and BCL-2 Polypeptides | Oct 9, 2014 | Abandoned |
Array
(
[id] => 10361014
[patent_doc_number] => 20150246019
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-03
[patent_title] => 'METHODS TO MOBILIZE PROGENITOR/STEM CELLS'
[patent_app_type] => utility
[patent_app_number] => 14/506297
[patent_app_country] => US
[patent_app_date] => 2014-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12293
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14506297
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/506297 | METHODS TO MOBILIZE PROGENITOR/STEM CELLS | Oct 2, 2014 | Abandoned |
Array
(
[id] => 11047524
[patent_doc_number] => 20160244482
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-25
[patent_title] => 'Method of Extracting Protein'
[patent_app_type] => utility
[patent_app_number] => 15/024253
[patent_app_country] => US
[patent_app_date] => 2014-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13084
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 28
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15024253
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/024253 | Method of Extracting Protein | Sep 23, 2014 | Abandoned |
Array
(
[id] => 11090745
[patent_doc_number] => 20160287713
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-06
[patent_title] => 'MODIFIED THERAPEUTIC AGENTS AND COMPOSITIONS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/917689
[patent_app_country] => US
[patent_app_date] => 2014-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 58081
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14917689
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/917689 | Modified therapeutic agents and compositions thereof | Sep 11, 2014 | Issued |
Array
(
[id] => 10979992
[patent_doc_number] => 20160176937
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-23
[patent_title] => 'SHORT PEPTIDES DERIVED FROM VDAC1, COMPOSITIONS AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/907445
[patent_app_country] => US
[patent_app_date] => 2014-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14677
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14907445
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/907445 | Short peptides derived from VDAC1, compositions and methods of use thereof | Jul 23, 2014 | Issued |
Array
(
[id] => 11083797
[patent_doc_number] => 20160280762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-29
[patent_title] => 'GLP-1 ANALOG FUSION PROTEIN AND PREPARATION METHOD AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/909143
[patent_app_country] => US
[patent_app_date] => 2014-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9626
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14909143
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/909143 | GLP-1 ANALOG FUSION PROTEIN AND PREPARATION METHOD AND USE THEREOF | Jul 22, 2014 | Abandoned |
Array
(
[id] => 10621640
[patent_doc_number] => 09340578
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-17
[patent_title] => 'Inhibitors targeting human ghrelin O-acyltransferase'
[patent_app_type] => utility
[patent_app_number] => 14/328800
[patent_app_country] => US
[patent_app_date] => 2014-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 1572
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14328800
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/328800 | Inhibitors targeting human ghrelin O-acyltransferase | Jul 10, 2014 | Issued |
Array
(
[id] => 9799785
[patent_doc_number] => 20150011729
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-08
[patent_title] => 'NUCLEOTIDE REPEAT EXPANSION-ASSOCIATED POLYPEPTIDES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/324336
[patent_app_country] => US
[patent_app_date] => 2014-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 26385
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14324336
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/324336 | NUCLEOTIDE REPEAT EXPANSION-ASSOCIATED POLYPEPTIDES AND USES THEREOF | Jul 6, 2014 | Abandoned |
Array
(
[id] => 10804648
[patent_doc_number] => 20160150805
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-02
[patent_title] => 'COMPOSITIONS AND NUTRITIONAL PRODUCTS WITH IMPROVED EMULSION STABILITY'
[patent_app_type] => utility
[patent_app_number] => 14/901327
[patent_app_country] => US
[patent_app_date] => 2014-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9566
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14901327
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/901327 | COMPOSITIONS AND NUTRITIONAL PRODUCTS WITH IMPROVED EMULSION STABILITY | Jun 26, 2014 | Abandoned |
Array
(
[id] => 9858408
[patent_doc_number] => 20150038421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-05
[patent_title] => 'FACTOR VIII COMPOSITIONS AND METHODS OF MAKING AND USING SAME'
[patent_app_type] => utility
[patent_app_number] => 14/317888
[patent_app_country] => US
[patent_app_date] => 2014-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 116892
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14317888
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/317888 | FACTOR VIII COMPOSITIONS AND METHODS OF MAKING AND USING SAME | Jun 26, 2014 | Abandoned |
Array
(
[id] => 11054446
[patent_doc_number] => 20160251408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-01
[patent_title] => 'THROMBIN CLEAVABLE LINKER WITH XTEN AND ITS USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/894108
[patent_app_country] => US
[patent_app_date] => 2014-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 45595
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14894108
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/894108 | THROMBIN CLEAVABLE LINKER WITH XTEN AND ITS USES THEREOF | Jun 26, 2014 | Abandoned |
Array
(
[id] => 10822039
[patent_doc_number] => 20160168204
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-16
[patent_title] => 'METHOD FOR PURIFYING OLIGOSACCHARIDE PEPTIDE'
[patent_app_type] => utility
[patent_app_number] => 14/392207
[patent_app_country] => US
[patent_app_date] => 2014-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 8325
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14392207
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/392207 | METHOD FOR PURIFYING OLIGOSACCHARIDE PEPTIDE | Jun 26, 2014 | Abandoned |
Array
(
[id] => 10797174
[patent_doc_number] => 20160143331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-26
[patent_title] => 'LIQUID FOOD COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 14/897893
[patent_app_country] => US
[patent_app_date] => 2014-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10524
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14897893
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/897893 | LIQUID FOOD COMPOSITION | Jun 15, 2014 | Abandoned |
Array
(
[id] => 10789968
[patent_doc_number] => 20160136124
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-19
[patent_title] => 'ADMINISTRATION OF A FOOD COMPOSITION PRODUCT'
[patent_app_type] => utility
[patent_app_number] => 14/899797
[patent_app_country] => US
[patent_app_date] => 2014-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4829
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14899797
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/899797 | ADMINISTRATION OF A FOOD COMPOSITION PRODUCT | Jun 12, 2014 | Abandoned |